Chen HZ - Search Results

1

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy.

Dong X, Xia S, Du S, Zhu MH, Lai X, Yao SQ, Chen HZ, Fang C. Dong X, et al. Among authors: chen hz. ACS Cent Sci. 2023 Sep 22;9(10):1864-1893. doi: 10.1021/acscentsci.3c00702. eCollection 2023 Oct 25. ACS Cent Sci. 2023. PMID: 37901179 Free PMC article. Review.

2

Liposomes-enabled cancer chemoimmunotherapy.

Zhang L, Shi J, Zhu MH, Huang Y, Lu Q, Sun P, Chen HZ, Lai X, Fang C. Zhang L, et al. Among authors: chen hz. Biomaterials. 2025 Feb;313:122801. doi: 10.1016/j.biomaterials.2024.122801. Epub 2024 Sep 3. Biomaterials. 2025. PMID: 39236630 Review.

3

Self-assembled PROTACs enable protein degradation to reprogram the tumor microenvironment for synergistically enhanced colorectal cancer immunotherapy.

Lu X, Jin J, Wu Y, Lin J, Zhang X, Lu S, Zhang J, Zhang C, Ren M, Chen H, Zhang W, Luan X. Lu X, et al. Bioact Mater. 2024 Sep 25;43:255-272. doi: 10.1016/j.bioactmat.2024.09.022. eCollection 2025 Jan. Bioact Mater. 2024. PMID: 39386219 Free PMC article.

4

Promising natural products targeting protein tyrosine phosphatase SHP2 for cancer therapy.

Lu J, Yu D, Li H, Qin P, Chen H, Chen L. Lu J, et al. Phytother Res. 2024 Apr 1. doi: 10.1002/ptr.8185. Online ahead of print. Phytother Res. 2024. PMID: 38558278 Review.

5

Insights into therapeutic peptides in the cancer-immunity cycle: Update and challenges.

Zhang X, Wu Y, Lin J, Lu S, Lu X, Cheng A, Chen H, Zhang W, Luan X. Zhang X, et al. Acta Pharm Sin B. 2024 Sep;14(9):3818-3833. doi: 10.1016/j.apsb.2024.05.013. Epub 2024 May 13. Acta Pharm Sin B. 2024. PMID: 39309492 Free PMC article. Review.

6

Tachyplesin I and its derivatives: A pharmaco-chemical perspective on their antimicrobial and antitumor potential.

Lu S, Lin J, Jin J, Zhang L, Guan Y, Chen H, Wu Y, Zhang W, Luan X. Lu S, et al. Expert Opin Drug Discov. 2022 Dec;17(12):1407-1423. doi: 10.1080/17460441.2023.2157402. Expert Opin Drug Discov. 2022. PMID: 36503335 Review.

7

Ginkgo biloba Extract Drives Gut Flora and Microbial Metabolism Variation in a Mouse Model of Alzheimer's Disease.

Yu T, Xing Y, Gao Q, Wang D, Chen H, Wang H, Zhang Y. Yu T, et al. Pharmaceutics. 2023 Dec 8;15(12):2746. doi: 10.3390/pharmaceutics15122746. Pharmaceutics. 2023. PMID: 38140087 Free PMC article.

8

In Silico Discovery of Stapled Peptide Inhibitor Targeting the Nur77-PPARγ Interaction and Its Anti-Breast-Cancer Efficacy.

Bian H, Liang X, Lu D, Lin J, Lu X, Jin J, Zhang L, Wu Y, Chen H, Zhang W, Luan X. Bian H, et al. Adv Sci (Weinh). 2024 Jul;11(26):e2308435. doi: 10.1002/advs.202308435. Epub 2024 Apr 29. Adv Sci (Weinh). 2024. PMID: 38682467 Free PMC article.

9

Decoding β-catenin associated protein-protein interactions: Emerging cancer therapeutic opportunities.

Yan Y, Gong Y, Liang X, Xiong Q, Lin J, Wu Y, Zhang L, Chen H, Jin J, Luan X. Yan Y, et al. Biochim Biophys Acta Rev Cancer. 2024 Dec 4;1880(1):189232. doi: 10.1016/j.bbcan.2024.189232. Online ahead of print. Biochim Biophys Acta Rev Cancer. 2024. PMID: 39643250 Review.

10

TRIM4 enhances small-molecule-induced neddylated-degradation of CORO1A for triple negative breast cancer therapy.

Gu WJ, Liu XX, Shen YW, Gong YT, Chen YL, Lin J, Lu D, Zhang LJ, Chen HZ, Jin Y, Zhan ZJ, Zhang WD, Jin JM, Luan X. Gu WJ, et al. Among authors: chen hz. Theranostics. 2024 Oct 21;14(18):7023-7041. doi: 10.7150/thno.97662. eCollection 2024. Theranostics. 2024. PMID: 39629122 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

803 results

Search Page

Filters